You are here

  • Home
  • Archive
  • Volume 15, Issue 4
  • Recalcitrant digital calcinosis cutis successfully treated with intralesional sodium thiosulfate under digital nerve blockade

Article Text

Article menu
Download PDFPDF
Case Reports: Novel treatment (new drug/interventions; established drug/procedure in new situation)
Recalcitrant digital calcinosis cutis successfully treated with intralesional sodium thiosulfate under digital nerve blockade
  1. Quynh Le1,
  2. Aaron Robinson1,
  3. Wendy Stevens2 and
  4. Jane Li1
  1. 1Dermatology, St Vincent's Hospital Melbourne Pty Ltd, Fitzroy, Victoria, Australia
  2. 2Rheumatology, St Vincent's Hospital Melbourne Pty Ltd, Fitzroy, Victoria, Australia
  1. Correspondence to Dr Quynh Le; Quynh.le{at}uqconnect.edu.au

Abstract

Dystrophic calcinosis cutis can be associated with severe pain, decreased mobility, increased risk of infection and significantly decreased quality of life. We report a case of recalcitrant calcinosis cutis on the background of eosinophilic fasciitis, which achieved rapid reduction in calcium deposits following a novel injecting protocol of intralesional sodium thiosulfate.

  • Dermatology
  • Skin
  • Therapeutic indications

https://doi.org/10.1136/bcr-2021-248707

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    View Full Text

    Footnotes

    • Contributors QL was responsible for the write up and editing of the manuscript. AR contributed in editing the manuscript. WS contributed in reviewing the manuscript. JL supervised and contributed in editing the manuscript.

    • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

    • Case reports provide a valuable learning resource for the scientific community and can indicate areas of interest for future research. They should not be used in isolation to guide treatment choices or public health policy.

    • Competing interests None declared.

    • Provenance and peer review Not commissioned; externally peer reviewed.